Invention Grant
- Patent Title: Rabies glycoprotein virus-like particles (VLPS)
-
Application No.: US13883745Application Date: 2011-11-07
-
Publication No.: US09724405B2Publication Date: 2017-08-08
- Inventor: Gale Smith , Ye Liu
- Applicant: Gale Smith , Ye Liu
- Applicant Address: US MD Gaithersburg
- Assignee: Novavax, Inc.
- Current Assignee: Novavax, Inc.
- Current Assignee Address: US MD Gaithersburg
- Agency: Cooley LLP
- International Application: PCT/US2011/059602 WO 20111107
- International Announcement: WO2012/061815 WO 20120510
- Main IPC: A61K39/205
- IPC: A61K39/205 ; C07K14/00 ; A61K39/12 ; C07K14/005 ; A61K39/00
Abstract:
The present invention is generally related to virus-like particles (VLPs) comprising rabies virus (RV) glycoproteins (G proteins) and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of rabies virus infection.
Public/Granted literature
- US20140178419A1 RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS) Public/Granted day:2014-06-26
Information query
